T2 Biosystems Inc (FRA:3T2)
€ 4.06 -0.15 (-3.56%) Market Cap: 67.24 Mil Enterprise Value: 106.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Q3 2019 T2 Biosystems Inc Earnings Call Transcript

Nov 12, 2019 / 01:30PM GMT
Release Date Price: €242 (+1.68%)
Operator

Welcome to T2 Biosystems 2019 Third Quarter Financial Results Conference Call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to Zack Kubow of the W2O Group. You may begin.

Zack Kubow
W2O Group - Group Director

Thank you, operator, and good morning, everyone. Thanks for joining us for the T2 Biosystems' Third Quarter 2019 Financial Results Conference Call. On the call to discuss the results and operational highlights for the quarter ended September 30, 2019, are Chairman and CEO, John McDonough; and Chief Financial Officer, John Sprague. We are also joined by Tom Lowery, Chief Scientific Officer.

The executive team will open the call with some prepared remarks, followed by a question-and-answer period. I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Those include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot